SUTRO BIOPHARMA, INC. (STRO) › Shareholders' EquitySUTRO BIOPHARMA, INC. (STRO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$93.90M2016: -$90.90M2017: -$109.00M2018: $131.54M2019: $97.79M2020: $332.05M2021: $252.56M2022: $217.05M2023: $149.65M2024: $44.60M2025: -$132.45M-$132.45M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$132.45M-397.0%2024$44.60M-70.2%2023$149.65M-31.1%2022$217.05M-14.1%2021$252.56M-23.9%2020$332.05M+239.6%2019$97.79M-25.7%2018$131.54M+220.7%2017-$109.00M-19.9%2016-$90.90M+3.2%2015-$93.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share